OTCMKTS:BOPCF BioPharma Credit (BOPCF) Stock Price, News & Analysis $0.91 +0.03 (+3.56%) As of 09/26/2025 Add Share Share Stock Analysis Stock AnalysisChartDividendShort InterestBuy This Stock About BioPharma Credit Stock (OTCMKTS:BOPCF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioPharma Credit alerts:Sign Up Key Stats Today's Range$0.91▼$0.9150-Day Range$0.84▼$0.9352-Week Range$0.78▼$0.94Volume1 shsAverage Volume541,229 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios. Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms. BioPharma Credit’s financing model often fills gaps left by traditional equity markets and bank lenders, enabling emerging and mid-market life sciences businesses to advance critical research and development programs. The trust pursues a rigorous due-diligence process, assessing clinical outlook, intellectual property strength and market potential before structuring bespoke credit facilities that align with each borrower’s funding requirements. Geographically, BioPharma Credit concentrates its investments in North America and select European markets, reflecting the region’s concentration of biotech clusters and research hubs. Its portfolio spans a variety of therapeutic areas, including oncology, rare diseases and immunology. The company’s management team draws on deep sector expertise in biopharma finance, aiming to balance yield generation with downside protection through collateral-backed lending and active portfolio monitoring.AI Generated. May Contain Errors. Read More Receive BOPCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BOPCF Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com BOPCF Stock Analysis - Frequently Asked Questions How have BOPCF shares performed this year? BioPharma Credit's stock was trading at $0.8130 at the start of the year. Since then, BOPCF shares have increased by 12.3% and is now trading at $0.9131. How do I buy shares of BioPharma Credit? Shares of BOPCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorN/A Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:BOPCF CIKN/A Webwww.bpcruk.com Phone011 44 1392 477 503FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:BOPCF) was last updated on 9/30/2025 by MarketBeat.com Staff From Our PartnersAn Early Move On The Next Shift In CoinLitecoin is already processing 500,000+ daily transactions, integrated with PayPal and Revolut, and now one fi...Market Tactic | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredBuy this stock tomorrowFamed futurist Eric Fry just unveiled his “Sell This, Buy That” strategy — including 7 free trade ideas like a...InvestorPlace | SponsoredThe 5th financial revolution is bigger than AIBacktests show this revolutionary technology could have transformed the 10 worst S&P stocks into winners. Turn...TradeSmith | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.